BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22050060)

  • 1. Drug-eluting stent thrombosis after 2029 days of placement: longest ever reported interval between drug-eluting stent placement and very late thrombosis.
    Akhtar M; Waked A; Bhat H; Khalid M; Teli S; Saiful FB; Lafferty J; Bhat T
    Future Cardiol; 2011 Nov; 7(6):745-8. PubMed ID: 22050060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-eluting stent thrombosis 1,659 days after stent deployment: case report and literature review.
    Al-Dehneh A; Virk H; Alkhouri Y; Hamdan A; Bikkina M
    Tex Heart Inst J; 2010; 37(3):343-6. PubMed ID: 20548819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extremely late drug-eluting stent thrombosis: 2037 days after deployment.
    Layland J; Jellis C; Whitbourn R
    Cardiovasc Revasc Med; 2009; 10(1):55-7. PubMed ID: 19159856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of early versus late clopidogrel discontinuation on stent thrombosis following percutaneous coronary intervention with first- and second-generation drug-eluting stents.
    Loh JP; Torguson R; Pendyala LK; Omar A; Chen F; Satler LF; Pichard AD; Waksman R
    Am J Cardiol; 2014 Jun; 113(12):1968-76. PubMed ID: 24767975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of biodegradable polymer-coated sirolimus-eluting stents in "real-world" practice: 18-month clinical and 9-month angiographic outcomes.
    Han Y; Jing Q; Xu B; Yang L; Liu H; Shang X; Jiang T; Li Z; Zhang H; Li H; Qiu J; Liu Y; Li Y; Chen X; Gao R;
    JACC Cardiovasc Interv; 2009 Apr; 2(4):303-9. PubMed ID: 19463441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angioplasty for the late stent thrombosis, the new technical challenge: a single centre experience.
    Goel PK; Gill GS
    Int J Cardiol; 2008 Jan; 123(3):335-7. PubMed ID: 17343935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions.
    Mauri L; Kereiakes DJ; Normand SL; Wiviott SD; Cohen DJ; Holmes DR; Bangalore S; Cutlip DE; Pencina M; Massaro JM
    Am Heart J; 2010 Dec; 160(6):1035-41, 1041.e1. PubMed ID: 21146655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlates and outcomes of late and very late drug-eluting stent thrombosis: results from DESERT (International Drug-Eluting Stent Event Registry of Thrombosis).
    Waksman R; Kirtane AJ; Torguson R; Cohen DJ; Ryan T; Räber L; Applegate R; Waxman S; Gordon P; Kaneshige K; Leon MB;
    JACC Cardiovasc Interv; 2014 Oct; 7(10):1093-102. PubMed ID: 25240540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stent thrombosis with an aneurysm 7 years after a drug eluting stent implantation.
    Patil P; Sethi A; Kaul U
    Indian Heart J; 2014; 66(2):216-9. PubMed ID: 24814120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled trial in second-generation zotarolimus-eluting Resolute stents versus everolimus-eluting Xience V stents in real-world patients: the TWENTE trial.
    von Birgelen C; Basalus MW; Tandjung K; van Houwelingen KG; Stoel MG; Louwerenburg JH; Linssen GC; Saïd SA; Kleijne MA; Sen H; Löwik MM; van der Palen J; Verhorst PM; de Man FH
    J Am Coll Cardiol; 2012 Apr; 59(15):1350-61. PubMed ID: 22341737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes with 6 months dual antiplatelet therapy after implantation of biolimus-A9 drug eluting coronary stents.
    Cockburn J; Pareek N; Poliacikova P; Saraf S; Williams R; Dhillon G; Robinson D; Gerber R; Hatrick R; Blows L; de Belder A; Hildick-Smith D
    Int J Cardiol; 2014 Mar; 172(1):185-9. PubMed ID: 24462139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between aspirin/clopidogrel resistance and intra-stent thrombi assessed by follow-up optical coherence tomography after drug-eluting stent implantation.
    Park J; Shin DH; Kim BK; Her AY; Kim YH; Choi HH; Kim JS; Ko YG; Choi D; Jang Y; Hong MK
    Eur Heart J Cardiovasc Imaging; 2013 Dec; 14(12):1181-6. PubMed ID: 23657678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late-term clinical outcomes with zotarolimus- and sirolimus-eluting stents. 5-year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions).
    Kandzari DE; Mauri L; Popma JJ; Turco MA; Gurbel PA; Fitzgerald PJ; Leon MB
    JACC Cardiovasc Interv; 2011 May; 4(5):543-50. PubMed ID: 21596327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Very late stent thrombosis due to DES fracture: description of a case and review of potential causes.
    Lee SW; Tam FC; Chan KK
    Catheter Cardiovasc Interv; 2011 Dec; 78(7):1101-5. PubMed ID: 21523887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence, timing, and correlates of stent thrombosis with the polymeric paclitaxel drug-eluting stent: a TAXUS II, IV, V, and VI meta-analysis of 3,445 patients followed for up to 3 years.
    Ellis SG; Colombo A; Grube E; Popma J; Koglin J; Dawkins KD; Stone GW
    J Am Coll Cardiol; 2007 Mar; 49(10):1043-51. PubMed ID: 17349883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis shows similar risk of thrombosis after drug-eluting stent, bare-metal stent, or angioplasty.
    Fuchs AT; Kuehnl A; Pelisek J; Rolland PH; Mekkaoui C; Netz H; Nikol S
    Endothelium; 2008; 15(1):93-100. PubMed ID: 18568949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Very late thrombosis of a drug-eluting stent deployed during primary angioplasty for ST-elevation myocardial infarction.
    Rigattieri S; Patrizi R; Silvestri P; Di Russo C; Musto C; Ferraiuolo G; Palamara A; Loschiavo P
    J Cardiovasc Med (Hagerstown); 2006 Oct; 7(10):771-4. PubMed ID: 17001240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Balancing hemorrhagic and thrombotic complications in a patient with a very late paclitaxel-eluting stent thrombosis: a clinical case report.
    Esposito G; Cassese S; Gargiulo G; Sannino A; Schiattarella GG; Piscione F; Chiariello M
    J Cardiovasc Med (Hagerstown); 2011 May; 12(5):366-9. PubMed ID: 20407382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous dual coronary very late stent thrombosis following noncardiac surgery.
    Parikh SV; Parikh A; Brilakis ES; Banerjee S
    Cardiovasc Revasc Med; 2010; 11(3):172-4. PubMed ID: 20599170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravascular ultrasound-guided percutaneous coronary interventions in contemporary practice.
    Bonello L; De Labriolle A; Lemesle G; Roy P; Steinberg DH; Pichard AD; Waksman R
    Arch Cardiovasc Dis; 2009 Feb; 102(2):143-51. PubMed ID: 19303582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.